FRANKFURT (Reuters) -Swiss drugmaker Roche on Thursday lifted its full-year profit guidance, even after nine-month sales were burdened by foreign exchange effects to come in below expectations. In a statement, the group said it projected a gain in adjusted earnings per share in the "high single to low double digit" percentage range. The was up from a previous guidance for the figures to grow by a "high single digit" percentage. It confirmed its outlook for mid single-digit sales growth. The brighter ear ...